The Eastern Cape Department of Health has launched a new treatment plan for people suffering from drug-resistant tuberculosis. The Bedaquiline, Pretomanid, Linezolid, and Levofloxacin (BPaL-L) regimen is a three-drug, six-month, all-oral regimen. Sakina Kamwendo spoke to the Deputy Director General of the Department of Health in the Eastern Cape.